TP53 and neoplasm: Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C.A single nucleotide polymorphism in the MDM2 promoter attenuatesthe p53 tumor suppressor pathway and accelerates tumor formationin humans.